Ocuphire Pharma Results

Current Conventional Treatment is Challenging for Patients Access and Time Burden are Further Barriers for DR Patient Compliance Patient-Reported Barriers to Follow-Up Treatment (N = 209) Adjusted Odds Ratio (95% CI)* 1.22 (0.63-2.00) 1.91 (1.02-3.57) 4.35 (2.14-8.86) 1.15 (0.41-3.22) 1.81 (0.59-5.51) 2.14 (0.60-7.58) 0.92 (0.27-3.12) 0.70 (0.20-2.41) Reported Barriers Long waiting times Other medical or physical condition Forgot to come Unable to leave work responsibilities Other incidental obligations Lack of an escort Unhappy with previous care Financial cost * adjusted for age, gender, insurance type, severity of DR Lu AJ, et al. Analysis of patient-reported barriers to diabetic retinopathy follow-up. Ophthalmic Surg Lasers Imaging Retina. 2019;50(2):99-105. Ocuphire Prenner J et al. Am J Ophthalmol, 2015;160(4):725-731.e1. PHARMA Office Visit Time Commitments Mean: 90 min Range: 13-261 min DR patients are generally asymptomatic which contributes to poor adherence and compliance 24

View entire presentation